Innova Captab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DUT01020
  • NSEID: INNOVACAP
  • BSEID: 544067
INR
706.00
-2.85 (-0.4%)
BSENSE

Dec 05

BSE+NSE Vol: 6.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Net Sales
1,243.68
1,081.31
926.38
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,243.68
1,081.31
926.38
Raw Material Cost
799.82
696.12
646.61
Purchase of Finished goods
39.22
35.54
44.79
(Increase) / Decrease In Stocks
-24.94
-3.32
0.17
Employee Cost
116.78
90.66
54.80
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
126.64
107.85
66.37
Total Expenditure (Excl Depreciation)
1,057.52
926.85
812.73
Operating Profit (PBDIT) excl Other Income
186.16
154.46
113.65
Other Income
12.05
12.49
9.20
Operating Profit (PBDIT)
198.21
166.95
122.85
Interest
2.41
21.46
19.97
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
195.80
145.49
102.88
Depreciation
24.78
15.96
11.08
Profit Before Tax
171.02
129.53
91.80
Tax
42.76
35.18
23.84
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
128.26
94.35
67.95
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
128.26
94.35
67.95
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.26
94.35
67.95
Equity Capital
57.23
57.23
48.00
Face Value
10.0
10.0
10.0
Reserves
902.19
773.67
228.51
Earnings per share (EPS)
22.41
16.49
14.16
Diluted Earnings per share
22.41
18.66
14.16
Operating Profit Margin (Excl OI)
14.97%
14.28%
12.27%
Gross Profit Margin
15.74%
13.45%
11.11%
PAT Margin
10.31%
8.73%
7.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 15.02% vs 16.72% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 35.94% vs 38.85% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 20.52% vs 35.91% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -88.77% vs 7.46% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Innova Captab With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,243.68
921.93
321.75
34.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,243.68
921.93
321.75
34.90%
Raw Material Cost
799.82
585.46
214.36
36.61%
Purchase of Finished goods
39.22
2.61
36.61
1,402.68%
(Increase) / Decrease In Stocks
-24.94
-43.85
18.91
43.12%
Employee Cost
116.78
86.36
30.42
35.22%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
126.64
174.17
-47.53
-27.29%
Total Expenditure (Excl Depreciation)
1,057.52
804.75
252.77
31.41%
Operating Profit (PBDIT) excl Other Income
186.16
117.18
68.98
58.87%
Other Income
12.05
27.47
-15.42
-56.13%
Operating Profit (PBDIT)
198.21
144.65
53.56
37.03%
Interest
2.41
14.54
-12.13
-83.43%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
195.80
130.11
65.69
50.49%
Depreciation
24.78
34.55
-9.77
-28.28%
Profit Before Tax
171.02
95.56
75.46
78.97%
Tax
42.76
-0.19
42.95
22,605.26%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
128.26
95.76
32.50
33.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
128.26
95.76
32.50
33.94%
Share in Profit of Associates
0.00
3.90
-3.90
-100.00%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.26
99.66
28.60
28.70%
Equity Capital
57.23
50.72
6.51
12.84%
Face Value
10.00
10.00
0.00
Reserves
902.19
1,216.57
-314.38
-25.84%
Earnings per share (EPS)
22.41
19.65
2.76
14.05%
Diluted Earnings per share
22.41
19.65
2.76
14.05%
Operating Profit Margin (Excl OI)
14.97%
12.71%
0.00
2.26%
Gross Profit Margin
15.74%
14.11%
0.00
1.63%
PAT Margin
10.31%
10.39%
0.00
-0.08%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,243.68 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.02% vs 16.72% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 128.26 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 35.94% vs 38.85% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 186.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.52% vs 35.91% in Mar 2024

Annual - Interest
Interest 2.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -88.77% vs 7.46% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.97%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024